Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men

Anita M. van den Hoek(Netherlands Organisation for Applied Scientific Research)

Scientific Reports

March 3, 2021

10.1038/s41598-021-83974-8

Cited by 22

Related Papers

A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology

|Cells|2020|42

Translatability of mouse muscle-aging for humans: the role of sex

|GeroScience|2024|16

Caloric Restriction Combined with Immobilization as Translational Model for Sarcopenia Expressing Key-Pathways of Human Pathology

|Aging and Disease|2023|5

Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for <scp>MASH</scp> ‐Associated Fibrosis

|The FASEB Journal|2025|2